Alpine Global Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Alpine Global Management’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,663	Closed	-$59	–	715
2022 Q1	$59	Buy	+12,663	New	+$37.8K	0.01%	305
2021 Q1	–	Sell	-32,720	Closed	-$105K	–	430
2020 Q4	$105K	Buy	+32,720	New	+$109K	0.02%	154
2016 Q3	–	Sell	-17,559	Closed	-$60K	–	238
2016 Q2	$60K	Buy	+17,559	New	+$80.6K	0.03%	159

Other funds holding CTIC

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return